Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk ALX Oncology Holdings Inc. per 2025 Jun 30 adalah -118.47 MM.
- Nilai net income untuk ALX Oncology Holdings Inc. per 2025 Jun 30 adalah -116.57 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -118.47 | -116.57 | |
2025-03-31 | -136.53 | -130.02 | |
2024-12-31 | -142.47 | -134.85 | |
2024-09-30 | -159.88 | -151.16 | |
2024-06-30 | -180.59 | -171.44 | |
2024-03-31 | -175.84 | -166.20 | |
2023-12-31 | -170.28 | -160.81 | |
2023-09-30 | -154.47 | -146.04 | |
2023-06-30 | -137.88 | -130.37 | |
2023-03-31 | -134.89 | -129.13 | |
2022-12-31 | -127.44 | -123.48 | |
2022-09-30 | -123.69 | -121.21 | |
2022-06-30 | -111.58 | -110.46 | |
2022-03-31 | -94.09 | -93.81 | |
2021-12-31 | -83.56 | -83.46 | |
2021-09-30 | 0.00 | -72.91 | -73.80 |
2021-06-30 | 0.00 | -58.14 | -59.41 |
2021-03-31 | 0.53 | -52.63 | -54.47 |
2020-12-31 | 1.18 | -43.66 | -45.74 |
2020-09-30 | 2.40 | -33.57 | -34.73 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -2.17.
- laba per saham yang terdilusi untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -2.17.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -2.17 | -2.17 |
2025-03-31 | -2.45 | -2.45 |
2024-12-31 | -2.58 | |
2024-09-30 | -2.97 | -2.97 |
2024-06-30 | -3.57 | -3.57 |
2024-03-31 | -3.67 | -3.67 |
2023-12-31 | -3.74 | |
2023-09-30 | -3.57 | -3.57 |
2023-06-30 | -3.19 | -3.19 |
2023-03-31 | -3.17 | -3.17 |
2022-12-31 | -3.03 | |
2022-09-30 | -2.98 | -2.98 |
2022-06-30 | -2.72 | -2.72 |
2022-03-31 | -2.32 | -2.32 |
2021-12-31 | -2.07 | |
2021-09-30 | -1.86 | -1.86 |
2021-06-30 | -1.62 | -1.62 |
2021-03-31 | -2.08 | -2.08 |
2020-12-31 | -2.76 | |
2020-09-30 | -4.18 | -4.18 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk ALX Oncology Holdings Inc. per 2025 Jun 30 adalah -105.49 MM.
- Nilai cash from investing activities untuk ALX Oncology Holdings Inc. per 2025 Jun 30 adalah 108.84 MM.
- Nilai kas dari aktivitas pendanaan untuk ALX Oncology Holdings Inc. per 2025 Jun 30 adalah 0.42 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -105.49 | 108.84 | 0.42 |
2025-03-31 | -108.65 | 87.43 | 27.80 |
2024-12-31 | -121.91 | 86.26 | 30.82 |
2024-09-30 | -129.54 | 36.41 | 89.66 |
2024-06-30 | -135.33 | 23.53 | 89.29 |
2024-03-31 | -140.47 | 28.84 | 62.48 |
2023-12-31 | -130.36 | 44.66 | 59.29 |
2023-09-30 | -111.35 | 72.27 | 9.62 |
2023-06-30 | -111.08 | 73.14 | 9.59 |
2023-03-31 | -96.36 | -9.20 | 9.67 |
2022-12-31 | -89.22 | -235.42 | 9.86 |
2022-09-30 | -86.04 | -250.88 | 0.89 |
2022-06-30 | -80.02 | -264.97 | 1.47 |
2022-03-31 | -83.64 | -188.84 | 1.77 |
2021-12-31 | -68.10 | -4.92 | 2.47 |
2021-09-30 | -64.23 | -0.42 | 190.31 |
2021-06-30 | -48.92 | 0.61 | 360.17 |
2021-03-31 | -34.46 | 0.61 | 358.67 |
2020-12-31 | -38.29 | 0.61 | 462.88 |
2020-09-30 | -27.55 | 0.68 | 280.45 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah 0.25.
- p/tbv untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah 0.25.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.25 | 0.25 | |
2025-03-31 | 0.31 | 0.31 | |
2024-12-31 | 0.64 | 0.64 | |
2024-09-30 | -0.61 | 0.63 | 0.63 |
2024-06-30 | -1.83 | 1.85 | 1.85 |
2024-03-31 | 3.02 | 3.02 | |
2023-12-31 | -5.08 | 4.39 | 4.39 |
2023-09-30 | -1.52 | 0.93 | 0.93 |
2023-06-30 | -2.30 | 1.24 | 1.24 |
2023-03-31 | -1.49 | 0.70 | |
2022-12-31 | 1.60 | 1.60 | |
2022-09-30 | 1.23 | 1.23 | |
2022-06-30 | -3.50 | 0.96 | 0.96 |
2022-03-31 | -8.23 | 1.89 | 1.89 |
2021-12-31 | -11.82 | 2.15 | 2.15 |
2021-09-30 | -50.15 | 7.36 | 7.36 |
2021-06-30 | |||
2021-03-31 | -11.15 | 1.45 | 1.45 |
2020-12-31 | -13.16 | 1.40 | 1.40 |
2020-09-30 | -16.14 | 2.22 | 2.22 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -11.28.
- EBIT (3 tahun) / EV untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -12.49.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -11.28 | -12.49 |
2025-03-31 | -4.94 | -5.25 |
2024-12-31 | -1.86 | -1.79 |
2024-09-30 | -1.75 | -1.49 |
2024-06-30 | -0.55 | -0.43 |
2024-03-31 | -0.29 | -0.22 |
2023-12-31 | -0.20 | -0.16 |
2023-09-30 | -0.77 | -0.59 |
2023-06-30 | -0.53 | -0.41 |
2023-03-31 | -0.85 | -0.62 |
2022-12-31 | -0.30 | -0.19 |
2022-09-30 | -0.34 | -0.23 |
2022-06-30 | -0.55 | -0.36 |
2022-03-31 | -0.26 | -0.16 |
2021-12-31 | -0.15 | -0.09 |
2021-09-30 | -0.02 | -0.01 |
2021-06-30 | ||
2021-03-31 | -0.30 | -0.16 |
2020-12-31 | -0.13 | -0.07 |
2020-09-30 | -0.07 | -0.02 |
Efektivitas Manajemen
- roa untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -0.61.
- roe untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -0.79.
- roic untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -1.24.
- croic untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah 0.06.
- ocroic untuk ALX Oncology Holdings Inc. pada 2025 Jun 30 adalah -1.04.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.61 | -0.79 | -1.24 | 0.06 | -1.04 |
2025-03-31 | -0.63 | -0.82 | -1.03 | -0.04 | -0.93 |
2024-12-31 | -0.62 | -0.80 | -0.98 | -0.02 | -0.84 |
2024-09-30 | -0.78 | -1.02 | -0.94 | -0.12 | -0.74 |
2024-06-30 | -0.60 | -0.69 | -0.92 | -0.27 | -0.78 |
2024-03-31 | -0.52 | -0.61 | -0.78 | -0.13 | -0.63 |
2023-12-31 | -0.46 | -0.51 | -0.79 | -0.16 | -0.61 |
2023-09-30 | -0.38 | -0.41 | -0.57 | -0.12 | -0.49 |
2023-06-30 | -0.37 | -0.41 | -0.57 | -0.12 | -0.49 |
2023-03-31 | -0.34 | -0.36 | -0.50 | -0.37 | -0.38 |
2022-12-31 | -0.30 | -0.30 | -0.41 | -1.14 | -0.29 |
2022-09-30 | -0.28 | -0.27 | -0.41 | -1.14 | -0.29 |
2022-06-30 | -0.22 | -0.23 | -0.34 | -1.06 | -0.25 |
2022-03-31 | -0.19 | -0.20 | -0.27 | -0.77 | -0.24 |
2021-12-31 | -0.17 | -0.17 | -0.23 | -0.19 | -0.16 |
2021-09-30 | -0.23 | -0.24 | -0.18 | 0.31 | -0.12 |
2021-06-30 | -0.58 | -0.66 | -0.15 | 0.76 | -0.12 |
2021-03-31 | -0.50 | -0.55 | -0.13 | 0.76 | -0.08 |
2020-12-31 | -4.28 | -0.11 | 0.98 | -0.09 | |
2020-09-30 | -3.79 | -0.13 | 0.98 | -0.11 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | 0.09 | -103.36 | -99.87 |
2020-12-31 | -38.70 | -36.94 | |
2020-09-30 | 0.09 | -14.50 | -14.02 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1810182 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |